134 related articles for article (PubMed ID: 6316505)
1. Bromine residue at hydrophilic region influences biological activity of aplysiatoxin, a tumor promoter.
Shimomura K; Mullinix MG; Kakunaga T; Fujiki H; Sugimura T
Science; 1983 Dec; 222(4629):1242-4. PubMed ID: 6316505
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of aplysiatoxin, debromoaplysiatoxin, and teleocidin on receptor binding and phospholipid metabolism.
Horowitz AD; Fujiki H; Weinstein IB; Jeffrey A; Okin E; Moore RE; Sugimura T
Cancer Res; 1983 Apr; 43(4):1529-35. PubMed ID: 6299522
[TBL] [Abstract][Full Text] [Related]
3. Activation of the EBV-cycle and aggregation of human blood lymphocytes by the tumor promoters teleocidin, lyngbyatoxin A, aplysiatoxin and debromoaplysiatoxin.
Eliasson L; Kallin B; Patarroyo M; Klein G; Fujiki H; Sugimura T
Int J Cancer; 1983 Jan; 31(1):7-11. PubMed ID: 6299973
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of tumor promotion and multistage carcinogenesis.
Weinstein IB; Arcoleo J; Backer J; Jeffrey A; Hsiao WL; Gattoni-Celli S; Kirschmeier P; Okin E
Princess Takamatsu Symp; 1983; 14():59-74. PubMed ID: 6097583
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of epidermal growth factor binding to mouse embryonal carcinoma cells by phorbol esters mediated by specific phorbol ester receptors.
Salomon DS
J Biol Chem; 1981 Aug; 256(15):7958-66. PubMed ID: 6267031
[No Abstract] [Full Text] [Related]
6. Tumor promoters block tyrosine-specific phosphorylation of the epidermal growth factor receptor.
Friedman B; Frackelton AR; Ross AH; Connors JM; Fujiki H; Sugimura T; Rosner MR
Proc Natl Acad Sci U S A; 1984 May; 81(10):3034-8. PubMed ID: 6328489
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptors interact with transforming growth factors produced by certain human tumor cells and are distinct from specific membrane receptors for phorbol and ingenol esters.
Todaro GJ; De Larco JE; Shoyab M
Carcinog Compr Surv; 1982; 7():443-62. PubMed ID: 6279294
[No Abstract] [Full Text] [Related]
8. Stimulation of human monocyte oxidative burst and related cytotoxicity by tumor-promoting and non-tumor-promoting diterpene esters, indole alkaloids and polyacetate-type agents.
Keisari Y; Geva I; Flescher E; Goldin H; Lavie G
Int J Cancer; 1985 Oct; 36(4):467-72. PubMed ID: 3930412
[TBL] [Abstract][Full Text] [Related]
9. Similarity of teleocidin B and phorbol ester tumour promoters in effects on membrane receptors.
Umezawa K; Weinstein IB; Horowitz A; Fujiki H; Matsushima T; Sugimura T
Nature; 1981 Apr; 290(5805):411-3. PubMed ID: 6261139
[TBL] [Abstract][Full Text] [Related]
10. Estimation of tumor promoting activity and structure-function relationships of aplysiatoxins.
Suganuma M; Fujiki H; Tahira T; Cheuk C; Moore RE; Sugimura T
Carcinogenesis; 1984 Mar; 5(3):315-8. PubMed ID: 6323046
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of tumor promoters on phorbol-ester-receptor binding and membrane fluorescence anisotropy in C3H 10T 1/2 cells.
Tran PL; Castagna M; Sala M; Vassent G; Horowitz AD; Schachter D; Weinstein LB
Eur J Biochem; 1983 Jan; 130(1):155-60. PubMed ID: 6297894
[No Abstract] [Full Text] [Related]
12. The third class of new tumor promoters, polyacetates (debromoaplysiatoxin and aplysiatoxin), can differentiate biological actions relevant to tumor promoters.
Fujiki H; Suganuma M; Nakayasu M; Hoshino H; Moore RE; Sugimura T
Gan; 1982 Jun; 73(3):495-7. PubMed ID: 7129014
[TBL] [Abstract][Full Text] [Related]
13. A new tumor-promoting agent, dihydroteleocidin B, markedly enhances chemically induced malignant cell transformation.
Hirakawa T; Kakunaga T; Fujiki H; Sugimura T
Science; 1982 Apr; 216(4545):527-9. PubMed ID: 6280280
[TBL] [Abstract][Full Text] [Related]
14. Specific protein interacting with a tumor promoter, debromoaplysiatoxin, in bovine serum is alpha 1-acid glycoprotein.
Ueyama H; Sasaki I; Shimomura K; Suganuma M
J Cancer Res Clin Oncol; 1995; 121(4):211-8. PubMed ID: 7751319
[TBL] [Abstract][Full Text] [Related]
15. Promoter-induced cellular responses closely correlated with the enhancement of cell transformation.
Kakunaga T; Hirakawa T; Shimomura K; Sugimura T
Princess Takamatsu Symp; 1983; 14():303-13. PubMed ID: 6097582
[TBL] [Abstract][Full Text] [Related]
16. Effect of tunicamycin on receptors for tumor promoters.
Solanki V; Logani MK; Slaga TJ
Cancer Lett; 1982 Sep; 16(3):319-25. PubMed ID: 6295623
[TBL] [Abstract][Full Text] [Related]
17. Binding studies of [3H]lyngbyatoxin A and [3H]debromoaplysiatoxin to the phorbol ester receptor in a mouse epidermal particulate fraction.
Moore RE; Patterson GM; Entzeroth M; Morimoto H; Suganuma M; Hakii H; Fujiki H; Sugimura T
Carcinogenesis; 1986 Apr; 7(4):641-4. PubMed ID: 3698197
[TBL] [Abstract][Full Text] [Related]
18. Binding of phorbol dibutyrate and epidermal growth factor to cultured human epidermal cells.
Greenebaum E; Nicolaides M; Eisinger M; Vogel RH; Weinstein IB
J Natl Cancer Inst; 1983 Mar; 70(3):435-41. PubMed ID: 6300498
[TBL] [Abstract][Full Text] [Related]
19. The effects of teleocidin and aplysiatoxin tumor promoters on epithelial tight junctions and transepithelial permeability: comparison to phorbol esters.
Mullin JM; McGinn MT; Snock KV; Imaizumi S
Carcinogenesis; 1990 Mar; 11(3):377-85. PubMed ID: 2311179
[TBL] [Abstract][Full Text] [Related]
20. Bryostatins: potent, new mitogens that mimic phorbol ester tumor promoters.
Smith JB; Smith L; Pettit GR
Biochem Biophys Res Commun; 1985 Nov; 132(3):939-45. PubMed ID: 3907633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
